NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $261,000 | -72.6% | 7,935 | -43.0% | 0.02% | -66.7% |
Q3 2018 | $954,000 | +347.9% | 13,927 | +219.4% | 0.06% | +361.5% |
Q2 2018 | $213,000 | -77.8% | 4,360 | -51.8% | 0.01% | -73.5% |
Q1 2018 | $960,000 | +278.0% | 9,039 | +112.5% | 0.05% | +276.9% |
Q4 2017 | $254,000 | +10.4% | 4,254 | -68.9% | 0.01% | -23.5% |
Q4 2015 | $230,000 | – | 13,662 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |